Autism Spectrum Disorder: Early Signs and Evaluation

Autism spectrum disorder (ASD) is a neurodevelopmental condition characterized by persistent differences in social communication, social interaction, and the presence of restricted or repetitive behaviors. The American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) formally defines ASD as a single diagnostic category encompassing what were previously separate diagnoses, including Autistic Disorder, Asperger's Syndrome, and Pervasive Developmental Disorder–Not Otherwise Specified. Early identification significantly changes the trajectory of outcomes, making recognition of signs before age 3 a clinical priority. This page covers how ASD is defined and classified, how the evaluation process works, the scenarios in which concerns typically surface, and the boundaries that guide clinical decision-making.

Definition and scope

ASD affects an estimated 1 in 36 children in the United States, according to the CDC's Autism and Developmental Disabilities Monitoring (ADDM) Network 2023 report. That prevalence figure represents a marked increase from the 1 in 150 estimate published by the ADDM Network in 2000, reflecting both expanded diagnostic criteria following the DSM-5 revision in 2013 and improved screening practices.

The DSM-5 organizes ASD along two core symptom domains:

  1. Social communication and social interaction deficits — including difficulty with back-and-forth conversation, reduced sharing of interests or emotions, trouble with nonverbal communicative behaviors (eye contact, facial expression, body language), and challenges developing and maintaining relationships.
  2. Restricted, repetitive patterns of behavior, interests, or activities — including stereotyped or repetitive motor movements, insistence on sameness or inflexible adherence to routines, highly restricted fixated interests, and hyperreactivity or hyporeactivity to sensory input.

The DSM-5 further assigns one of three severity levels to each domain, rated Level 1 ("requiring support"), Level 2 ("requiring substantial support"), or Level 3 ("requiring very substantial support"). These levels communicate the degree of support needed rather than fixed labels of functioning.

ASD co-occurs with intellectual disability in approximately 31% of cases and with language delay in a substantial proportion, according to ADDM Network surveillance data. Epilepsy, attention-deficit/hyperactivity disorder, anxiety disorders, and gastrointestinal conditions are among the most frequently documented co-occurring conditions. The regulatory and coverage frameworks governing ASD-related services — including Medicaid mandates and state insurance parity laws — directly affect which evaluations and therapies families can access.

How it works

ASD evaluation is a multistage process governed by professional standards from the American Academy of Pediatrics (AAP) and the American Academy of Neurology (AAN). The AAP recommends ASD-specific screening at the 18-month and 24-month well-child visits for all children, in addition to routine developmental surveillance at every preventive visit from birth onward (AAP Clinical Practice Guidelines, 2020).

The evaluation sequence typically follows these phases:

  1. Developmental surveillance — At every well-child visit, the clinician asks structured questions about milestones, observes the child's behavior, and notes parent concerns. Tools such as the Ages and Stages Questionnaires (ASQ) support this step. The well-child visit schedule determines the cadence of surveillance.
  2. ASD-specific screening — The Modified Checklist for Autism in Toddlers, Revised with Follow-Up (M-CHAT-R/F) is the most widely validated screening instrument for children 16 to 30 months. A positive screen does not confer a diagnosis; it triggers the next phase.
  3. Comprehensive diagnostic evaluation — This involves a licensed clinician (developmental-behavioral pediatrician, child psychiatrist, pediatric neurologist, or licensed psychologist) conducting a structured observation using tools such as the Autism Diagnostic Observation Schedule, Second Edition (ADOS-2) and a caregiver interview using the Autism Diagnostic Interview–Revised (ADI-R). Cognitive testing, speech-language assessment, and adaptive behavior measures are typically included.
  4. Medical workup — Genetic testing (including chromosomal microarray) is recommended by the AAP for children with ASD, given that an identifiable genetic cause is found in approximately 20–25% of cases (AAP Policy Statement on Evaluation of the Child with Global Developmental Delay). Hearing evaluation is standard prior to or concurrent with the diagnostic process (see hearing and vision testing procedures).
  5. Reporting and planning — Findings are synthesized into a diagnostic report that specifies DSM-5 criteria met, severity levels per domain, co-occurring conditions, and recommended interventions.

Behavioral and developmental evaluations, including those for ASD, are described in greater detail in the behavioral and psychological evaluation section and the developmental delays evaluation page.

Common scenarios

Concerns about ASD surface in three distinct clinical contexts.

Toddler presentation (12–30 months): Parents report that the child does not respond to their name consistently, does not point to share interest (protodeclarative pointing), has few or no words by 16 months, or has lost language that was previously present. Loss of previously acquired language or social skills at any age is a red flag that warrants immediate evaluation, not watchful waiting.

Preschool presentation (3–5 years): The child may have functional language but shows difficulty with reciprocal conversation, prefers parallel play over cooperative play, has intense focused interests (e.g., memorizing train schedules or planetary data), and reacts with significant distress to unexpected changes in routine. Sensory differences — covering ears in moderate-noise environments, refusing certain food textures — often become more apparent in this period.

School-age presentation (6–12 years): Some children, particularly those with average or above-average cognitive ability, are not identified until academic and social demands increase. These children may have developed compensatory strategies that masked earlier signs. Girls are disproportionately identified later than boys, a pattern documented in research published through the ADDM Network and attributed in part to differential expression of social camouflaging behaviors.

The growth charts and developmental milestones reference provides the normative benchmarks against which these presentations are measured.

Decision boundaries

Distinguishing ASD from other conditions requires explicit diagnostic boundaries.

ASD vs. language disorder: A child with a primary language disorder typically shows intact social engagement — they make eye contact, initiate social bids, and point to share interests — but has difficulty with expressive or receptive language. In ASD, the social communication differences extend beyond language and involve the quality of social interaction itself.

ASD vs. ADHD: Attention-deficit/hyperactivity disorder produces difficulties with sustained attention and impulse control, but does not involve the restricted, repetitive behavior pattern or the specific social communication profile of ASD. The two conditions co-occur in a substantial proportion of children; the ADHD diagnosis and treatment page addresses that overlap. DSM-5 allows dual diagnosis of ASD and ADHD when both criteria sets are independently met.

ASD vs. social anxiety disorder: Social anxiety disorder involves fear of negative evaluation in social situations; children with social anxiety typically understand and desire social connection but avoid it due to fear. Children with ASD often show qualitative differences in understanding social cues rather than fear of judgment as the primary driver.

ASD vs. intellectual disability without ASD: Intellectual disability may involve language and adaptive behavior delays, but when social development is commensurate with the child's developmental level rather than below it, an ASD diagnosis is not warranted.

The signs that a child needs a specialist page provides a practical framework for determining when concerns exceed the scope of general pediatric monitoring. Because ASD is a lifelong condition, coordinating services across educational, medical, and behavioral systems is addressed in the chronic illness care coordination section. A broad orientation to the pediatric care landscape, including how conditions like ASD fit within the scope of child health, is available on the pediatrics overview page.

References

The law belongs to the people. Georgia v. Public.Resource.Org, 590 U.S. (2020)